Related Experiment Video
Updated: Feb 24, 2026

TurboID-Based Proximity Labeling for In Planta Identification of Protein-Protein Interaction Networks
Published on: May 17, 2020
PVLens: Enhancing Pharmacovigilance Through Automated Label Extraction
Jeffery L Painter1, Gregory E Powell1, Andrew Bate2,3
1GSK, Durham, NC, USA.
PVLens is a new automated system for drug safety data extraction from FDA labels, improving pharmacovigilance. It offers a more accurate and up-to-date alternative to static resources like SIDER.
Area of Science:
- Pharmacovigilance and Drug Safety
- Health Informatics
- Regulatory Science
Background:
- Existing drug safety databases like SIDER are outdated and static, hindering real-time pharmacovigilance.
- Accurate and continuously updated safety information is crucial for monitoring drug risks.
- There is a need for automated systems to efficiently extract and standardize safety data from regulatory documents.
Purpose of the Study:
- To introduce PVLens, an automated system for extracting labeled drug safety information from FDA Structured Product Labels (SPLs).
- To map extracted safety terms to the Medical Dictionary for Regulatory Activities (MedDRA) terminology.
- To provide a scalable, accurate, and continuously updated resource for pharmacovigilance.
Main Methods:
- Developed an automated system (PVLens) to extract safety information from FDA SPLs.
- Integrated term mapping to MedDRA for standardized data representation.
- Implemented a web-based review tool for expert oversight and validation.
- Validated the system against 97 drug labels.
Main Results:
- PVLens achieved a high F1 score of 0.882 in validation.
- The system demonstrated high recall (0.983) and moderate precision (0.799).
- PVLens successfully extracted and mapped safety information, outperforming static resources.
Conclusions:
- PVLens offers a scalable and accurate solution for drug safety data extraction.
- The system enhances real-time pharmacovigilance by providing contemporaneous insights.
- PVLens represents a significant advancement over outdated, static drug safety databases.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
12:30Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
Published on: March 5, 2012
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...